{"id":19871,"date":"2014-04-21T06:50:45","date_gmt":"2014-04-21T10:50:45","guid":{"rendered":"https:\/\/cablemanpro.com\/wallstreetpr\/?p=19871"},"modified":"2014-04-21T06:50:45","modified_gmt":"2014-04-21T10:50:45","slug":"abbott-laboratories-nyseabts-spinoff-abbivie-urged-u-s-court-to-review-ruling-in-hiv-drug-trail","status":"publish","type":"post","link":"https:\/\/cablemanpro.com\/wallstreetpr\/abbott-laboratories-nyseabts-spinoff-abbivie-urged-u-s-court-to-review-ruling-in-hiv-drug-trail-19871","title":{"rendered":"Abbott Laboratories (NYSE:ABT)\u2019S Spinoff Abbivie Urged U.S. Court To Review Ruling In HIV Drug Trail"},"content":{"rendered":"<p style=\"text-align: justify;\">Boston, MA 04\/21\/2014 (wallstreetpr) \u2013\u00a0A spinoff of <b>Abbott Laboratories (NYSE:ABT)<\/b> insisted on a federal appeals court in San Francisco to rethink its decision in the case against <b>Glaxo SmithKline plc (ADR) (NYSE:GSK).<\/b><\/p>\n<p style=\"text-align: justify;\">On Thursday, <b>AbbVie Inc (NYSE:ABBV)<\/b> urged the 9<sup>th<\/sup> U.S. Circuit Court of Appeals to revisit a preliminary three judge ruling according to which a gay man was inappropriately denied inclusion in jury service. The reason was the man\u2019s sexual orientation. AbbVie has now urged the full court to review the decision, but without agitating landmark constitutional security for lesbians and gays.<\/p>\n<p style=\"text-align: justify;\"><b>No Discrimination<\/b><\/p>\n<p style=\"text-align: justify;\">The San Francisco court in reaching that judgment in January ordered a new hearing for AbbVie Inc (NYSE:ABBV) \u00a0against Glaxo SmithKline plc (ADR) (NYSE:GSK).after AbbVie claimed that the ruling of the 9<sup>th<\/sup> Circuit requires review because of its capability to influence many other jury trials in the future. AbbVie, however, said that it does not seek the court to rethink a holding that focuses on the constitutional affects judges in many Western states are now required to apply at the time of evaluation of laws pertaining to rights for gay people. Abbott\u2019s lawyers said that the company condemns practices of inequity in various forms, including in the selection of a jury, and no such discrimination was witnessed in this case.<\/p>\n<p style=\"text-align: justify;\"><b>The Case<\/b><\/p>\n<p style=\"text-align: justify;\">Glaxo SmithKline plc (ADR) (NYSE:GSK)<b> <\/b>versus Abbott Laboratories (NYSE:ABT) case concerns the pricing of medications focusing on HIV, which is a controversial matter in the gay community. Glaxo claimed that Abbott increased the costs of the drug called Norvir so that it could maintain the growth in sales of its other HIV drug called Kaletra. Abbott was accused to have increased the price of Norvir, a drug which is capable of boosting the efficiency of other medications, by as much as 400% in 2003. In this issue, Glaxo had expected to win $571 million but ended up receiving only $3.5 million after the one month trial.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Boston, MA 04\/21\/2014 (wallstreetpr) \u2013\u00a0A spinoff of Abbott Laboratories (NYSE:ABT) insisted on a federal appeals court in San Francisco to rethink its decision in the [&hellip;]<\/p>\n","protected":false},"author":2,"featured_media":19872,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"rop_custom_images_group":[],"rop_custom_messages_group":[],"rop_publish_now":"initial","rop_publish_now_accounts":{"twitter_2902945987_2902945987":""},"rop_publish_now_history":[],"rop_publish_now_status":"pending","footnotes":""},"categories":[264],"tags":[3448,1593,6043,1592,1125,1735],"stock_ticker":[],"class_list":["post-19871","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-health","tag-abbott-laboratories-nyseabt","tag-abbvie-inc-nyseabbv","tag-glaxo-smithkline-plc-adr-nysegsk","tag-nyseabbv","tag-nyseabt","tag-nysegsk","entry"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v26.9 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Abbott Laboratories (NYSE:ABT)\u2019S Spinoff Abbivie Urged U.S. Court To Review Ruling In HIV Drug Trail - Wall Street PR<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/cablemanpro.com\/wallstreetpr\/abbott-laboratories-nyseabts-spinoff-abbivie-urged-u-s-court-to-review-ruling-in-hiv-drug-trail-19871\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Abbott Laboratories (NYSE:ABT)\u2019S Spinoff Abbivie Urged U.S. Court To Review Ruling In HIV Drug Trail - Wall Street PR\" \/>\n<meta property=\"og:description\" content=\"Boston, MA 04\/21\/2014 (wallstreetpr) \u2013\u00a0A spinoff of Abbott Laboratories (NYSE:ABT) insisted on a federal appeals court in San Francisco to rethink its decision in the [&hellip;]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/cablemanpro.com\/wallstreetpr\/abbott-laboratories-nyseabts-spinoff-abbivie-urged-u-s-court-to-review-ruling-in-hiv-drug-trail-19871\" \/>\n<meta property=\"og:site_name\" content=\"Wall Street PR\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/WallStreetPR\/\" \/>\n<meta property=\"article:published_time\" content=\"2014-04-21T10:50:45+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2014\/04\/download-3.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"400\" \/>\n\t<meta property=\"og:image:height\" content=\"104\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"Donna Fago\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Donna Fago\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/abbott-laboratories-nyseabts-spinoff-abbivie-urged-u-s-court-to-review-ruling-in-hiv-drug-trail-19871#article\",\"isPartOf\":{\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/abbott-laboratories-nyseabts-spinoff-abbivie-urged-u-s-court-to-review-ruling-in-hiv-drug-trail-19871\"},\"author\":{\"name\":\"Donna Fago\",\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/#\/schema\/person\/60ece280249b1fa366ae54f87bb8ae84\"},\"headline\":\"Abbott Laboratories (NYSE:ABT)\u2019S Spinoff Abbivie Urged U.S. Court To Review Ruling In HIV Drug Trail\",\"datePublished\":\"2014-04-21T10:50:45+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/abbott-laboratories-nyseabts-spinoff-abbivie-urged-u-s-court-to-review-ruling-in-hiv-drug-trail-19871\"},\"wordCount\":347,\"commentCount\":0,\"publisher\":{\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/#organization\"},\"image\":{\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/abbott-laboratories-nyseabts-spinoff-abbivie-urged-u-s-court-to-review-ruling-in-hiv-drug-trail-19871#primaryimage\"},\"thumbnailUrl\":\"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2014\/04\/download-3.jpg\",\"keywords\":[\"Abbott Laboratories (NYSE:ABT)\",\"AbbVie Inc. (NYSE:ABBV)\",\"Glaxo SmithKline plc (ADR) (NYSE:GSK)\",\"NYSE:ABBV\",\"NYSE:ABT\",\"NYSE:GSK\"],\"articleSection\":[\"Health\"],\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\/\/cablemanpro.com\/wallstreetpr\/abbott-laboratories-nyseabts-spinoff-abbivie-urged-u-s-court-to-review-ruling-in-hiv-drug-trail-19871#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/abbott-laboratories-nyseabts-spinoff-abbivie-urged-u-s-court-to-review-ruling-in-hiv-drug-trail-19871\",\"url\":\"https:\/\/cablemanpro.com\/wallstreetpr\/abbott-laboratories-nyseabts-spinoff-abbivie-urged-u-s-court-to-review-ruling-in-hiv-drug-trail-19871\",\"name\":\"Abbott Laboratories (NYSE:ABT)\u2019S Spinoff Abbivie Urged U.S. Court To Review Ruling In HIV Drug Trail - Wall Street PR\",\"isPartOf\":{\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/abbott-laboratories-nyseabts-spinoff-abbivie-urged-u-s-court-to-review-ruling-in-hiv-drug-trail-19871#primaryimage\"},\"image\":{\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/abbott-laboratories-nyseabts-spinoff-abbivie-urged-u-s-court-to-review-ruling-in-hiv-drug-trail-19871#primaryimage\"},\"thumbnailUrl\":\"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2014\/04\/download-3.jpg\",\"datePublished\":\"2014-04-21T10:50:45+00:00\",\"breadcrumb\":{\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/abbott-laboratories-nyseabts-spinoff-abbivie-urged-u-s-court-to-review-ruling-in-hiv-drug-trail-19871#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/cablemanpro.com\/wallstreetpr\/abbott-laboratories-nyseabts-spinoff-abbivie-urged-u-s-court-to-review-ruling-in-hiv-drug-trail-19871\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/abbott-laboratories-nyseabts-spinoff-abbivie-urged-u-s-court-to-review-ruling-in-hiv-drug-trail-19871#primaryimage\",\"url\":\"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2014\/04\/download-3.jpg\",\"contentUrl\":\"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2014\/04\/download-3.jpg\",\"width\":400,\"height\":104},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/abbott-laboratories-nyseabts-spinoff-abbivie-urged-u-s-court-to-review-ruling-in-hiv-drug-trail-19871#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/cablemanpro.com\/wallstreetpr\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Abbott Laboratories (NYSE:ABT)\u2019S Spinoff Abbivie Urged U.S. Court To Review Ruling In HIV Drug Trail\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/#website\",\"url\":\"https:\/\/cablemanpro.com\/wallstreetpr\/\",\"name\":\"Wall Street PR\",\"description\":\"Latest News From WallStreet\",\"publisher\":{\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/cablemanpro.com\/wallstreetpr\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/#organization\",\"name\":\"Wall Street PR\",\"url\":\"https:\/\/cablemanpro.com\/wallstreetpr\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2019\/10\/brand-logo.png\",\"contentUrl\":\"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2019\/10\/brand-logo.png\",\"width\":537,\"height\":70,\"caption\":\"Wall Street PR\"},\"image\":{\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/#\/schema\/logo\/image\/\"},\"sameAs\":[\"https:\/\/www.facebook.com\/WallStreetPR\/\",\"https:\/\/x.com\/WallstreetPRs\"]},{\"@type\":\"Person\",\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/#\/schema\/person\/60ece280249b1fa366ae54f87bb8ae84\",\"name\":\"Donna Fago\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2019\/06\/f15db860f556e28a86f628554c98485b.jpeg\",\"contentUrl\":\"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2019\/06\/f15db860f556e28a86f628554c98485b.jpeg\",\"caption\":\"Donna Fago\"},\"description\":\"I believe in writing content Informing investors with the knowledge they need to invest better today- I have been following the markets for many years and was asked to join the team at WallStreetPR.com recently due to my passion for the markets.\",\"sameAs\":[\"http:\/\/www.WallStreetPR.com\"],\"url\":\"https:\/\/cablemanpro.com\/wallstreetpr\/author\/darcie-fago\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Abbott Laboratories (NYSE:ABT)\u2019S Spinoff Abbivie Urged U.S. Court To Review Ruling In HIV Drug Trail - Wall Street PR","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/cablemanpro.com\/wallstreetpr\/abbott-laboratories-nyseabts-spinoff-abbivie-urged-u-s-court-to-review-ruling-in-hiv-drug-trail-19871","og_locale":"en_US","og_type":"article","og_title":"Abbott Laboratories (NYSE:ABT)\u2019S Spinoff Abbivie Urged U.S. Court To Review Ruling In HIV Drug Trail - Wall Street PR","og_description":"Boston, MA 04\/21\/2014 (wallstreetpr) \u2013\u00a0A spinoff of Abbott Laboratories (NYSE:ABT) insisted on a federal appeals court in San Francisco to rethink its decision in the [&hellip;]","og_url":"https:\/\/cablemanpro.com\/wallstreetpr\/abbott-laboratories-nyseabts-spinoff-abbivie-urged-u-s-court-to-review-ruling-in-hiv-drug-trail-19871","og_site_name":"Wall Street PR","article_publisher":"https:\/\/www.facebook.com\/WallStreetPR\/","article_published_time":"2014-04-21T10:50:45+00:00","og_image":[{"width":400,"height":104,"url":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2014\/04\/download-3.jpg","type":"image\/jpeg"}],"author":"Donna Fago","twitter_misc":{"Written by":"Donna Fago","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/cablemanpro.com\/wallstreetpr\/abbott-laboratories-nyseabts-spinoff-abbivie-urged-u-s-court-to-review-ruling-in-hiv-drug-trail-19871#article","isPartOf":{"@id":"https:\/\/cablemanpro.com\/wallstreetpr\/abbott-laboratories-nyseabts-spinoff-abbivie-urged-u-s-court-to-review-ruling-in-hiv-drug-trail-19871"},"author":{"name":"Donna Fago","@id":"https:\/\/cablemanpro.com\/wallstreetpr\/#\/schema\/person\/60ece280249b1fa366ae54f87bb8ae84"},"headline":"Abbott Laboratories (NYSE:ABT)\u2019S Spinoff Abbivie Urged U.S. Court To Review Ruling In HIV Drug Trail","datePublished":"2014-04-21T10:50:45+00:00","mainEntityOfPage":{"@id":"https:\/\/cablemanpro.com\/wallstreetpr\/abbott-laboratories-nyseabts-spinoff-abbivie-urged-u-s-court-to-review-ruling-in-hiv-drug-trail-19871"},"wordCount":347,"commentCount":0,"publisher":{"@id":"https:\/\/cablemanpro.com\/wallstreetpr\/#organization"},"image":{"@id":"https:\/\/cablemanpro.com\/wallstreetpr\/abbott-laboratories-nyseabts-spinoff-abbivie-urged-u-s-court-to-review-ruling-in-hiv-drug-trail-19871#primaryimage"},"thumbnailUrl":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2014\/04\/download-3.jpg","keywords":["Abbott Laboratories (NYSE:ABT)","AbbVie Inc. (NYSE:ABBV)","Glaxo SmithKline plc (ADR) (NYSE:GSK)","NYSE:ABBV","NYSE:ABT","NYSE:GSK"],"articleSection":["Health"],"inLanguage":"en-US","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/cablemanpro.com\/wallstreetpr\/abbott-laboratories-nyseabts-spinoff-abbivie-urged-u-s-court-to-review-ruling-in-hiv-drug-trail-19871#respond"]}]},{"@type":"WebPage","@id":"https:\/\/cablemanpro.com\/wallstreetpr\/abbott-laboratories-nyseabts-spinoff-abbivie-urged-u-s-court-to-review-ruling-in-hiv-drug-trail-19871","url":"https:\/\/cablemanpro.com\/wallstreetpr\/abbott-laboratories-nyseabts-spinoff-abbivie-urged-u-s-court-to-review-ruling-in-hiv-drug-trail-19871","name":"Abbott Laboratories (NYSE:ABT)\u2019S Spinoff Abbivie Urged U.S. Court To Review Ruling In HIV Drug Trail - Wall Street PR","isPartOf":{"@id":"https:\/\/cablemanpro.com\/wallstreetpr\/#website"},"primaryImageOfPage":{"@id":"https:\/\/cablemanpro.com\/wallstreetpr\/abbott-laboratories-nyseabts-spinoff-abbivie-urged-u-s-court-to-review-ruling-in-hiv-drug-trail-19871#primaryimage"},"image":{"@id":"https:\/\/cablemanpro.com\/wallstreetpr\/abbott-laboratories-nyseabts-spinoff-abbivie-urged-u-s-court-to-review-ruling-in-hiv-drug-trail-19871#primaryimage"},"thumbnailUrl":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2014\/04\/download-3.jpg","datePublished":"2014-04-21T10:50:45+00:00","breadcrumb":{"@id":"https:\/\/cablemanpro.com\/wallstreetpr\/abbott-laboratories-nyseabts-spinoff-abbivie-urged-u-s-court-to-review-ruling-in-hiv-drug-trail-19871#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/cablemanpro.com\/wallstreetpr\/abbott-laboratories-nyseabts-spinoff-abbivie-urged-u-s-court-to-review-ruling-in-hiv-drug-trail-19871"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/cablemanpro.com\/wallstreetpr\/abbott-laboratories-nyseabts-spinoff-abbivie-urged-u-s-court-to-review-ruling-in-hiv-drug-trail-19871#primaryimage","url":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2014\/04\/download-3.jpg","contentUrl":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2014\/04\/download-3.jpg","width":400,"height":104},{"@type":"BreadcrumbList","@id":"https:\/\/cablemanpro.com\/wallstreetpr\/abbott-laboratories-nyseabts-spinoff-abbivie-urged-u-s-court-to-review-ruling-in-hiv-drug-trail-19871#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/cablemanpro.com\/wallstreetpr\/"},{"@type":"ListItem","position":2,"name":"Abbott Laboratories (NYSE:ABT)\u2019S Spinoff Abbivie Urged U.S. Court To Review Ruling In HIV Drug Trail"}]},{"@type":"WebSite","@id":"https:\/\/cablemanpro.com\/wallstreetpr\/#website","url":"https:\/\/cablemanpro.com\/wallstreetpr\/","name":"Wall Street PR","description":"Latest News From WallStreet","publisher":{"@id":"https:\/\/cablemanpro.com\/wallstreetpr\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/cablemanpro.com\/wallstreetpr\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/cablemanpro.com\/wallstreetpr\/#organization","name":"Wall Street PR","url":"https:\/\/cablemanpro.com\/wallstreetpr\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/cablemanpro.com\/wallstreetpr\/#\/schema\/logo\/image\/","url":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2019\/10\/brand-logo.png","contentUrl":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2019\/10\/brand-logo.png","width":537,"height":70,"caption":"Wall Street PR"},"image":{"@id":"https:\/\/cablemanpro.com\/wallstreetpr\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/WallStreetPR\/","https:\/\/x.com\/WallstreetPRs"]},{"@type":"Person","@id":"https:\/\/cablemanpro.com\/wallstreetpr\/#\/schema\/person\/60ece280249b1fa366ae54f87bb8ae84","name":"Donna Fago","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/cablemanpro.com\/wallstreetpr\/#\/schema\/person\/image\/","url":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2019\/06\/f15db860f556e28a86f628554c98485b.jpeg","contentUrl":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2019\/06\/f15db860f556e28a86f628554c98485b.jpeg","caption":"Donna Fago"},"description":"I believe in writing content Informing investors with the knowledge they need to invest better today- I have been following the markets for many years and was asked to join the team at WallStreetPR.com recently due to my passion for the markets.","sameAs":["http:\/\/www.WallStreetPR.com"],"url":"https:\/\/cablemanpro.com\/wallstreetpr\/author\/darcie-fago"}]}},"_links":{"self":[{"href":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-json\/wp\/v2\/posts\/19871","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-json\/wp\/v2\/comments?post=19871"}],"version-history":[{"count":0,"href":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-json\/wp\/v2\/posts\/19871\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-json\/wp\/v2\/media\/19872"}],"wp:attachment":[{"href":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-json\/wp\/v2\/media?parent=19871"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-json\/wp\/v2\/categories?post=19871"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-json\/wp\/v2\/tags?post=19871"},{"taxonomy":"stock_ticker","embeddable":true,"href":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-json\/wp\/v2\/stock_ticker?post=19871"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}